+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Veterinary Drug Market Research Report by Drug Type (Anti-Infective, Anti-Inflammatory, and Parasiticide), Route of Administration, Animal Type, State - United States Forecast to 2027 - Cumulative Impact of COVID-19

  • PDF Icon

    Report

  • 151 Pages
  • July 2022
  • Region: United States
  • 360iResearch™
  • ID: 5124438
UP TO OFF until Dec 31st 2022
The United States Veterinary Drug Market size was estimated at USD 4,189.42 million in 2021, USD 4,656.17 million in 2022, and is projected to grow at a CAGR 7.67% to reach USD 6,529.26 million by 2027.

Market Statistics:


The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.

Market Segmentation & Coverage:


This research report categorizes the Veterinary Drug to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Drug Type, the market was studied across Anti-Infective, Anti-Inflammatory, and Parasiticide.
  • Based on Route of Administration, the market was studied across Oral, Parenteral, and Topical.
  • Based on Animal Type, the market was studied across Companion Animal and Livestock Animal.
  • Based on State, the market was studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas.

Cumulative Impact of COVID-19:


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:


We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Veterinary Drug market considering the current update on the conflict and its global response.

Competitive Strategic Window:


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:


The FPNV Positioning Matrix evaluates and categorizes the vendors in the Veterinary Drug Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:


The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:


The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the United States Veterinary Drug Market, including Bayer AG, Bimeda, Inc., Biogenesis Bago SA, Boehringer Ingelheim GmbH, Century Pharmaceuticals Limited, Ceva Sante Animale SA, Dechra Pharmaceuticals PLC, Elanco Animal Health Incorporated, Hester Biosciences Limited, Indian Immunologicals Ltd., Jurox Pty Ltd, Kindred Biosciences, Inc., Kyoritsu Seiyaku Corporation, Merck & Co., Inc., Neogen Corporation, Novartis AG, Pharmgate LLC, Phibro Animal Health Corporation, Vetoquinol SA, Virbac SA, and Zoetis Inc.

The report provides insights on the following pointers:


1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:


1. What is the market size and forecast of the United States Veterinary Drug Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the United States Veterinary Drug Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the United States Veterinary Drug Market?
4. What is the competitive strategic window for opportunities in the United States Veterinary Drug Market?
5. What are the technology trends and regulatory frameworks in the United States Veterinary Drug Market?
6. What is the market share of the leading vendors in the United States Veterinary Drug Market?
7. What modes and strategic moves are considered suitable for entering the United States Veterinary Drug Market?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.2. Restraints
5.1.3. Opportunities
5.1.4. Challenges
5.2. Cumulative Impact of COVID-19
6. Veterinary Drug Market, by Drug Type
6.1. Introduction
6.2. Anti-Infective
6.3. Anti-Inflammatory
6.4. Parasiticide
7. Veterinary Drug Market, by Route of Administration
7.1. Introduction
7.2. Oral
7.3. Parenteral
7.4. Topical
8. Veterinary Drug Market, by Animal Type
8.1. Introduction
8.2. Companion Animal
8.3. Livestock Animal
9. California Veterinary Drug Market10. Florida Veterinary Drug Market11. Illinois Veterinary Drug Market12. New York Veterinary Drug Market13. Ohio Veterinary Drug Market14. Pennsylvania Veterinary Drug Market15. Texas Veterinary Drug Market
16. Competitive Landscape
16.1. Fpnv Positioning Matrix
16.1.1. Quadrants
16.1.2. Business Strategy
16.1.3. Product Satisfaction
16.2. Market Ranking Analysis
16.3. Market Share Analysis, by Key Player
16.4. Competitive Scenario
16.4.1. Merger & Acquisition
16.4.2. Agreement, Collaboration, & Partnership
16.4.3. New Product Launch & Enhancement
16.4.4. Investment & Funding
16.4.5. Award, Recognition, & Expansion
17. Company Usability Profiles
17.1. Bayer Ag
17.2. Bimeda, Inc.
17.3. Biogenesis Bago Sa
17.4. Boehringer Ingelheim GmbH
17.5. Century Pharmaceuticals Limited
17.6. Ceva Sante Animale Sa
17.7. Dechra Pharmaceuticals plc
17.8. Elanco Animal Health Incorporated
17.9. Hester Biosciences Limited
17.10. Indian Immunologicals Ltd.
17.11. Jurox Pty Ltd
17.12. Kindred Biosciences, Inc.
17.13. Kyoritsu Seiyaku Corporation
17.14. Merck & Co., Inc.
17.15. Neogen Corporation
17.16. Novartis Ag
17.17. Pharmgate LLC
17.18. Phibro Animal Health Corporation
17.19. Vetoquinol Sa
17.20. Virbac Sa
17.21. Zoetis Inc
18. Appendix
18.1. Discussion Guide
18.2. License & Pricing
List of Figures
FIGURE 1. UNITED STATES VETERINARY DRUG MARKET: RESEARCH PROCESS
FIGURE 2. UNITED STATES VETERINARY DRUG MARKET SIZE, 2021 VS 2027 (USD MILLION)
FIGURE 3. UNITED STATES VETERINARY DRUG MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 4. UNITED STATES VETERINARY DRUG MARKET SIZE, BY STATE, 2021 VS 2027 (%)
FIGURE 5. UNITED STATES VETERINARY DRUG MARKET SIZE, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 6. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES VETERINARY DRUG MARKET SIZE, BY STATE, 2027
FIGURE 7. UNITED STATES VETERINARY DRUG MARKET DYNAMICS
FIGURE 8. UNITED STATES VETERINARY DRUG MARKET SIZE, BY DRUG TYPE, 2021 VS 2027 (%)
FIGURE 9. UNITED STATES VETERINARY DRUG MARKET SIZE, BY DRUG TYPE, 2021 VS 2027 (USD MILLION)
FIGURE 10. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES VETERINARY DRUG MARKET SIZE, BY DRUG TYPE, 2027
FIGURE 11. UNITED STATES VETERINARY DRUG MARKET SIZE, BY ANTI-INFECTIVE, 2019-2027 (USD MILLION)
FIGURE 12. UNITED STATES VETERINARY DRUG MARKET SIZE, BY ANTI-INFECTIVE, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 13. UNITED STATES VETERINARY DRUG MARKET SIZE, BY ANTI-INFLAMMATORY, 2019-2027 (USD MILLION)
FIGURE 14. UNITED STATES VETERINARY DRUG MARKET SIZE, BY ANTI-INFLAMMATORY, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 15. UNITED STATES VETERINARY DRUG MARKET SIZE, BY PARASITICIDE, 2019-2027 (USD MILLION)
FIGURE 16. UNITED STATES VETERINARY DRUG MARKET SIZE, BY PARASITICIDE, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 17. UNITED STATES VETERINARY DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2021 VS 2027 (%)
FIGURE 18. UNITED STATES VETERINARY DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2021 VS 2027 (USD MILLION)
FIGURE 19. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES VETERINARY DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2027
FIGURE 20. UNITED STATES VETERINARY DRUG MARKET SIZE, BY ORAL, 2019-2027 (USD MILLION)
FIGURE 21. UNITED STATES VETERINARY DRUG MARKET SIZE, BY ORAL, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 22. UNITED STATES VETERINARY DRUG MARKET SIZE, BY PARENTERAL, 2019-2027 (USD MILLION)
FIGURE 23. UNITED STATES VETERINARY DRUG MARKET SIZE, BY PARENTERAL, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 24. UNITED STATES VETERINARY DRUG MARKET SIZE, BY TOPICAL, 2019-2027 (USD MILLION)
FIGURE 25. UNITED STATES VETERINARY DRUG MARKET SIZE, BY TOPICAL, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 26. UNITED STATES VETERINARY DRUG MARKET SIZE, BY ANIMAL TYPE, 2021 VS 2027 (%)
FIGURE 27. UNITED STATES VETERINARY DRUG MARKET SIZE, BY ANIMAL TYPE, 2021 VS 2027 (USD MILLION)
FIGURE 28. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES VETERINARY DRUG MARKET SIZE, BY ANIMAL TYPE, 2027
FIGURE 29. UNITED STATES VETERINARY DRUG MARKET SIZE, BY COMPANION ANIMAL, 2019-2027 (USD MILLION)
FIGURE 30. UNITED STATES VETERINARY DRUG MARKET SIZE, BY COMPANION ANIMAL, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 31. UNITED STATES VETERINARY DRUG MARKET SIZE, BY LIVESTOCK ANIMAL, 2019-2027 (USD MILLION)
FIGURE 32. UNITED STATES VETERINARY DRUG MARKET SIZE, BY LIVESTOCK ANIMAL, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 33. CALIFORNIA VETERINARY DRUG MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 34. FLORIDA VETERINARY DRUG MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 35. ILLINOIS VETERINARY DRUG MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 36. NEW YORK VETERINARY DRUG MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 37. OHIO VETERINARY DRUG MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 38. PENNSYLVANIA VETERINARY DRUG MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 39. TEXAS VETERINARY DRUG MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 40. UNITED STATES VETERINARY DRUG MARKET: FPNV POSITIONING MATRIX, 2021
FIGURE 41. UNITED STATES VETERINARY DRUG MARKET SHARE, BY KEY PLAYER, 2021
FIGURE 42. COMPETITIVE SCENARIO ANALYSIS IN UNITED STATES VETERINARY DRUG MARKET, BY TYPE
List of Tables
TABLE 1. UNITED STATES VETERINARY DRUG MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
TABLE 3. UNITED STATES VETERINARY DRUG MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 4. UNITED STATES VETERINARY DRUG MARKET SIZE, BY STATE, 2019-2027 (USD MILLION)
TABLE 5. UNITED STATES VETERINARY DRUG MARKET SIZE, BY DRUG TYPE, 2019-2027 (USD MILLION)
TABLE 6. UNITED STATES VETERINARY DRUG MARKET SIZE, BY ANTI-INFECTIVE, BY STATE, 2019-2027 (USD MILLION)
TABLE 7. UNITED STATES VETERINARY DRUG MARKET SIZE, BY ANTI-INFLAMMATORY, BY STATE, 2019-2027 (USD MILLION)
TABLE 8. UNITED STATES VETERINARY DRUG MARKET SIZE, BY PARASITICIDE, BY STATE, 2019-2027 (USD MILLION)
TABLE 9. UNITED STATES VETERINARY DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 10. UNITED STATES VETERINARY DRUG MARKET SIZE, BY ORAL, BY STATE, 2019-2027 (USD MILLION)
TABLE 11. UNITED STATES VETERINARY DRUG MARKET SIZE, BY PARENTERAL, BY STATE, 2019-2027 (USD MILLION)
TABLE 12. UNITED STATES VETERINARY DRUG MARKET SIZE, BY TOPICAL, BY STATE, 2019-2027 (USD MILLION)
TABLE 13. UNITED STATES VETERINARY DRUG MARKET SIZE, BY ANIMAL TYPE, 2019-2027 (USD MILLION)
TABLE 14. UNITED STATES VETERINARY DRUG MARKET SIZE, BY COMPANION ANIMAL, BY STATE, 2019-2027 (USD MILLION)
TABLE 15. UNITED STATES VETERINARY DRUG MARKET SIZE, BY LIVESTOCK ANIMAL, BY STATE, 2019-2027 (USD MILLION)
TABLE 16. CALIFORNIA VETERINARY DRUG MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 17. CALIFORNIA VETERINARY DRUG MARKET SIZE, BY DRUG TYPE, 2019-2027 (USD MILLION)
TABLE 18. CALIFORNIA VETERINARY DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 19. CALIFORNIA VETERINARY DRUG MARKET SIZE, BY ANIMAL TYPE, 2019-2027 (USD MILLION)
TABLE 20. FLORIDA VETERINARY DRUG MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 21. FLORIDA VETERINARY DRUG MARKET SIZE, BY DRUG TYPE, 2019-2027 (USD MILLION)
TABLE 22. FLORIDA VETERINARY DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 23. FLORIDA VETERINARY DRUG MARKET SIZE, BY ANIMAL TYPE, 2019-2027 (USD MILLION)
TABLE 24. ILLINOIS VETERINARY DRUG MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 25. ILLINOIS VETERINARY DRUG MARKET SIZE, BY DRUG TYPE, 2019-2027 (USD MILLION)
TABLE 26. ILLINOIS VETERINARY DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 27. ILLINOIS VETERINARY DRUG MARKET SIZE, BY ANIMAL TYPE, 2019-2027 (USD MILLION)
TABLE 28. NEW YORK VETERINARY DRUG MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 29. NEW YORK VETERINARY DRUG MARKET SIZE, BY DRUG TYPE, 2019-2027 (USD MILLION)
TABLE 30. NEW YORK VETERINARY DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 31. NEW YORK VETERINARY DRUG MARKET SIZE, BY ANIMAL TYPE, 2019-2027 (USD MILLION)
TABLE 32. OHIO VETERINARY DRUG MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 33. OHIO VETERINARY DRUG MARKET SIZE, BY DRUG TYPE, 2019-2027 (USD MILLION)
TABLE 34. OHIO VETERINARY DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 35. OHIO VETERINARY DRUG MARKET SIZE, BY ANIMAL TYPE, 2019-2027 (USD MILLION)
TABLE 36. PENNSYLVANIA VETERINARY DRUG MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 37. PENNSYLVANIA VETERINARY DRUG MARKET SIZE, BY DRUG TYPE, 2019-2027 (USD MILLION)
TABLE 38. PENNSYLVANIA VETERINARY DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 39. PENNSYLVANIA VETERINARY DRUG MARKET SIZE, BY ANIMAL TYPE, 2019-2027 (USD MILLION)
TABLE 40. TEXAS VETERINARY DRUG MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 41. TEXAS VETERINARY DRUG MARKET SIZE, BY DRUG TYPE, 2019-2027 (USD MILLION)
TABLE 42. TEXAS VETERINARY DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 43. TEXAS VETERINARY DRUG MARKET SIZE, BY ANIMAL TYPE, 2019-2027 (USD MILLION)
TABLE 44. UNITED STATES VETERINARY DRUG MARKET: FPNV POSITIONING MATRIX - SCORES, 2021
TABLE 45. UNITED STATES VETERINARY DRUG MARKET: FPNV POSITIONING MATRIX - BUSINESS STRATEGY, 2021
TABLE 46. UNITED STATES VETERINARY DRUG MARKET: FPNV POSITIONING MATRIX - PRODUCT SATISFACTION, 2021
TABLE 47. UNITED STATES VETERINARY DRUG MARKET RANKING
TABLE 48. UNITED STATES VETERINARY DRUG MARKET SHARE, BY KEY PLAYER, 2021
TABLE 49. UNITED STATES VETERINARY DRUG MARKET MERGER & ACQUISITION
TABLE 50. UNITED STATES VETERINARY DRUG MARKET AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 51. UNITED STATES VETERINARY DRUG MARKET NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 52. UNITED STATES VETERINARY DRUG MARKET INVESTMENT & FUNDING
TABLE 53. UNITED STATES VETERINARY DRUG MARKET AWARD, RECOGNITION, & EXPANSION
TABLE 54. UNITED STATES VETERINARY DRUG MARKET: LICENSE & PRICING

Samples

Loading
LOADING...

Companies Mentioned

  • Bayer AG
  • Bimeda, Inc.
  • Biogenesis Bago SA
  • Boehringer Ingelheim GmbH
  • Century Pharmaceuticals Limited
  • Ceva Sante Animale SA
  • Dechra Pharmaceuticals PLC
  • Elanco Animal Health Incorporated
  • Hester Biosciences Limited
  • Indian Immunologicals Ltd.
  • Jurox Pty Ltd
  • Kindred Biosciences, Inc.
  • Kyoritsu Seiyaku Corporation
  • Merck & Co., Inc.
  • Neogen Corporation
  • Novartis AG
  • Pharmgate LLC
  • Phibro Animal Health Corporation
  • Vetoquinol SA
  • Virbac SA
  • Zoetis Inc

Methodology

Loading
LOADING...